Company CVAbout RPG Life Sciences Ltd 
RPG Life Sciences Ltd
Small Cap
Pharmaceuticals & Biotechnology
RPG Life Sciences Limited, formerly Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group. The Company is engaged in manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). RPG Life Sciences Limited was incorporated on March 29, 2007 with the name 'RPG Pharmaceuticals Limited' .
Company Coordinates
Company Details
RPG House, 463 Dr Annie Besant Road Worli Mumbai Maharashtra : 400030
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 13.23 Cr
Number of Shares
1.65 Cr
Face Value
INR 8.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
17-Oct-2016
1.65
13.23
2910
8
ESOP
17-Oct-2016
1.65
13.23
2910
8
ESOP
23-Jul-2014
1.65
13.23
864
8
ESOP
23-Jul-2014
1.65
13.23
864
8
ESOP
01-Nov-2010
1.65
13.23
28391
8
ESOP
01-Nov-2010
1.65
13.23
28391
8
ESOP
29-Sep-2010
1.65
13.21
1438000
8
Conversion of Warrants
29-Sep-2010
1.65
13.21
1438000
8
Conversion of Warrants
31-Mar-2010
1.51
12.06
700000
8
Conversion of Warrants
31-Mar-2010
1.51
12.06
700000
8
Conversion of Warrants
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 6 Schemes (3.2%)
FIIs
Held by 45 FIIs (1.11%)
Promoter with highest holding
Nucleus Life Trust (mr. Harsh Vardhan Goenka Is A Trustee) (53.94%)
Highest Public shareholder
Authum Investment And Infrastructure Limited (2.02%)
Individual Investors Holdings
15.37%
Board of Directors
Management
Designation
Remuneration
H V Goenka
Chairman
2.5 lacs
C L Jain
Non Executive Independent Director
3.95 lacs
Lalit S Kanodia
Non Executive Independent Director
2.6 lacs
Mahesh S Gupta
Non Executive Independent Director
3.79 lacs
Manoj K Maheshwari
Non Executive Independent Director
2.0 lacs
Narendra Ambwani
Non Executive Independent Director
2.64 lacs
Zahabiya Khorakiwala
Non Executive Independent Director
1.55 lacs
Yugal Sikri
Non Executive Independent Director
3.75 lacs
Sachin Nandgaonkar
Non Executive Director
3.1 lacs
C T Renganathan
Managing Director
2.48 cr
Rajesh Shirambekar
Company Secretary
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Preparations
323.83
98.08%
Other Operating Revenue - Export Incentives
5.39
1.63%
Other Operating Revenue - Scrap
0.85
0.26%
Pharmaceutical Preparations
Pharmaceutical Preparations
Other Operating Revenue - Export Incentives
Other Operating Revenue - Export Incentives
Other Operating Revenue - Scrap
Other Operating Revenue - Scrap
Stock DNARevenue and Profits:
Net Sales:
182 Cr
(Quarterly Results - Sep 2025)
Net Profit:
37 Cr
Pharmaceuticals & Biotechnology
INR 3,665 Cr (Small Cap)
33.00
34
1.09%
-0.40
20.12%
6.58
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
